The FDA is undergoing a strategic reevaluation of its policies under new leadership, prompted by rapid advancements in science and technology. Now is the time for FDA to pursue a proactive policy ...

Letters, Testimony and Comments BIO Comments on OMB Proposed Rule "Regulation for Federal Financial Assistance" July 13, 2026 Download Full Comments Below BIO Comments to OMB Download Discover More ...

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

Beijing CorreGene Biotechnology Co., Ltd., founded by several Peking University alumni, dedicated to the development of innovative therapeutics based on T-cell receptors (TCRs). CorreGene has ...

Day 3 of BIO 2026 looked ahead to biotech's next chapter: how AI could accelerate drug discovery, why U.S. biotechnology leadership is a national security priority, and what states can do to compete ...

As BIO 2026 comes to a close, we look ahead to biotech's sixth decade. Pioneering patients remind us why innovation matters, and experts outline what will shape biotech's next decade, and leaders warn ...

ICYMI: The PASTEUR Act was reintroduced in the Senate. Plus, more from BIO 2026, including the latest on the 340B program and what the media was covering at the Convention. (639 words, 3 minutes, 12 ...

On Tuesday, BIO 2026 attendees explored what it will take to maintain America's innovation edge, while a new industry report offered fresh evidence that capital is returning to the sector and emerging ...